No Data
No Data
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $86
Buy Rating Affirmed: Boston Scientific's Strong Performance and Upward Financial Projections
Sector Update: Health Care Stocks Advance in Afternoon Trading
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular Devices Leads To 2024 Guidance Hike Again
Top Midday Stories: Alphabet Posts Higher Results; Tesla Non-GAAP Earnings Fall; Visa's Higher Results; Thermo Fisher Scientific Adjusted Earnings Rise, Revenue Drops; T-Mobile US, KKR Forming Joint Venture to Acquire Metronet
On Paris : Thank you